Target intelligence / Profile preview

DNA-directed RNA polymerase I subunit E (POLR1E)

Target
POLR1E
Molecular classification
Enzyme, RNA polymerase subunit, Transcription factor complex component
01

Overview

DNA-directed RNA polymerase I subunit E (POLR1E) is a key structural and functional component of RNA polymerase I, a multi-subunit enzyme complex specialized for the transcription of ribosomal DNA (rDNA) into precursor rRNA in the nucleolus[3][1][4][5]. POLR1E, also referred to as RPA49, forms a heterodimer with RPA34 and plays a crucial role in promoting elongation and processivity of Pol I during rRNA synthesis[1][3]. As a central regulator of ribosome biogenesis, POLR1E is vital for sustaining high levels of cell growth and proliferation. Dysregulation of POLR1E or Pol I activity is implicated in several human diseases: Pol I activity is upregulated in many cancers to support increased protein synthesis demands, while mutations in Pol I subunits can lead to developmental disorders known as ribosomopathies (e.g., Treacher Collins syndrome)[3][4]. Inhibitors targeting Pol I or its transcription machinery are being explored as anti-cancer therapies[1][3].

Other names
RNA polymerase I subunit RPA49PAF53PRAF1RNA polymerase I subunit A49RNA polymerase I-associated factor 1RNA polymerase I-associated factor 53FLJ13390FLJ13970RPA49A49polymerase (RNA) I associated factor 1polymerase (RNA) I polypeptide E, 53kDapolymerase (RNA) I subunit E
02

Mechanism of action

Inhibition of ribosomal RNA synthesis, leading to nucleolar stress and apoptosis in cancer cells

03

Biological functions

Ribosomal RNA synthesisTranscription of rDNARegulation of ribosome biogenesisRegulation of cell growth and proliferation
04

Disease associations

CancerRibosomopathies (e.g., Treacher Collins syndrome, acrofacial dysostosis, hypomyelinating leukodystrophy)Aging
05

Safety considerations

Potential cytotoxicity in normal rapidly proliferating tissuesRisk of impaired ribosome function and associated side effects (myelosuppression, growth defects)
06

Interacting drugs

CX-5461 (inhibitor of RNA polymerase I transcription)

1 more in the full profile.

07

Biomarkers

Upregulation of RNA polymerase I activity or ribosomal RNA synthesis as a biomarker in certain cancers

Beyond the preview

Go deeper on DNA-directed RNA polymerase I subunit E (POLR1E).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNA-directed RNA polymerase I subunit E (POLR1E).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call